Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00000378Phase 4Completed
Phase 4, randomised, double-blind trial of sertraline in major depressive disorder (MDD) (2 arms), sponsored by New York State Psychiatric Institute. Primary endpoint: Hamilton Rating Scale for Depression at 12 weeks. Started Jul 1997; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00000378.